Payami, H, Nutt, J, Gancher, S, Bird, T, Gonzales McNeal, M, Seltzer, WK, Hussey, J, Lockhart, P, Gwinn-Hardy, K, Adam, A, Singleton, A, Hardy, J, and Farrer, M. SCA2 may present as Levodopa Responsive Parkinsonism. Movement Disorders Apr 18 (4):425-9, 2003.

Gonzales McNeal M, Moore MM, Zitzelberger T, Siemsen G, Oken B, and Kaye J. Abstract: Plasma Homocysteine and Brain Volume in Healthy Oldest Old. Neurology 60 (Suppl 1):A114, March 2003.

Marquis S, Moore MM, Howieson DB, Sexton G, Payami H, Kaye JA, Camicioli R. Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol. 2002 Apr;59(4):601-6.

Zareparsi S, Camicioli R, Sexton G, Bird T, Swanson P, Kaye J, Nutt J, Payami H. Age at onset of Parkinson disease and apolipoprotein E genotypes. Am J Med Genet. 2002 Jan 15;107(2):156-61.

Zareparsi S, James DM, Kaye JA, Bird TD, Schellenberg GD, Payami H. HLA-A2 homozygosity but not heterozygosity is associated with Alzheimer disease. Neurology. 2002 Mar 26;58(6):973-5.

Gonzales McNeal, M., S. Zareparsi, R. Camicioli, A. Dame, D. Howieson, J. Quinn, M. Ball, J. Kaye, and H. Payami, Predictors of healthy brain aging. J Gerontology A Biol Sci Med Sci, 2001. 56: B294-301.

Payami, H., N. Lee, S. Zareparsi, M. Gonzales McNeal, R. Camicioli, T. Bird, G. Sexton, S. Gancher, J. Kaye, and D. Calhoun, Parkinson's disease, CYP2D6 polymorphism, and age. Neurology, 2001. 56(10): 1363-70.

Poorkaj P, Grossman M, Steinbart E, Payami H, Sadovnick A, Nochlin D, Tabira T, Trojanowski JQ, Borson S, Galasko D, Reich S, Quinn B, Schellenberg G, Bird TD. Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol. 2001 Mar;58(3):383-7.

Wirdefeldt K, Bogdanovic N, Westerberg L, Payami H, Schalling M, Murdoch G. Expression of alpha-synuclein in the human brain: relation to Lewy body disease. Brain Res Mol Brain Res. 2001 Aug 15;92(1-2):58-65.

Payami H, Gonzales McNeal M, Zareparsi S, and Kaye J. Abstract: Cognitive health span (CHS): a target phenotype for healthy brain aging. Neurology, 2000.

Warwick Daw E, Payami H, Nemens EJ, Nochlin D, Bird TD, Schellenberg GD, Wijsman EM. The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet. 2000 Jan;66(1):196-204

Camicioli R, Kaye J, Payami H, Ball MJ, Murdoch G. Apolipoprotein E epsilon4 is associated with neuronal loss in the substantia nigra in Alzheimer's disease. Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):437-41.

Bird TD, Nochlin D, Poorkaj P, Cherrier M, Kaye J, Payami H, Peskind E, Lampe TH, Nemens E, Boyer PJ, Schellenberg GD. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L) Brain. 1999 Apr;122 ( Pt 4):741-56. Erratum in: Brain 1999 Jul;122(Pt 7):1398.

Houlden H, Rizzu P, Stevens M, de Knijff P, van Duijn CM, van Swieten JC, Heutink P, Perez-Tur J, Thomas V, Baker M, Morris H, Rossor M, Jannsen JC, Petersen RC, Dodd P, Dark F, Boeve B, Dickson D, Davies P, Pickering-Brown S, Mann D, Adamson J, Lynch T, Payami H, Hardy J, et al. Apolipoprotein E genotype does not affect the age of onset of dementia in families with defined tau mutations. Neurosci Lett. 1999 Feb 5;260(3):193-5. PMID: 10076900 [PubMed - indexed for

Payami H, Gonzales McNeal M, and Kaye J. Abstract: Biological Markers for Healthy Brain Aging: Evidence for Gene-Gender Interaction. Neurology 52 (Suppl 2):A251, 1999.

Clark LN, Poorkaj P, Wszolek Z, Geschwind DH, Nasreddine ZS, Miller B, Li D, Payami H, Awert F, Markopoulou K, Andreadis A, D'Souza I, Lee VM, Reed L, Trojanowski JQ, Zhukareva V, Bird T, Schellenberg G, Wilhelmsen KC. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13103-7.

Zareparsi S, Kaye J, Camicioli R, Kramer P, Nutt J, Bird T, Litt M, Payami H, Kay J. Analysis of the alpha-synuclein G209A mutation in familial Parkinson's disease. Lancet. 1998 Jan 3;351(9095):37-8. No abstract available. Erratum in: Lancet 1998 Mar 7;351(9104):760.

Zareparsi S, Kaye J, Camicioli R, Grimslid H, Oken B, Litt M, Nutt J, Bird T, Schellenberg G, Payami H.
Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes. Ann Neurol. 1997 Oct;42(4):655-8.

Payami H, Schellenberg GD, Zareparsi S, Kaye J, Sexton GJ, Head MA, Matsuyama SS, Jarvik LF, Miller B, McManus DQ, Bird TD, Katzman R, Heston L, Norman D, Small GW. Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease. Neurology. 1997 Aug;49(2):512-8.

Howieson DB, Dame A, Camicioli R, Sexton G, Payami H, Kaye JA. Cognitive markers preceding Alzheimer's dementia in the healthy oldest old. J Am Geriatr Soc. 1997 May;45(5):584-9.

Bird TD, Wijsman EM, Nochlin D, Leehey M, Sumi SM, Payami H, Poorkaj P, Nemens E, Rafkind M, Schellenberg GD. Chromosome 17 and hereditary dementia: linkage studies in three non-Alzheimer families and kindreds with late-onset FAD. Neurology. 1997 Apr;48(4):949-54.

Payami H, Grimslid H, Oken B, Camicioli R, Sexton G, Dame A, Howieson D, Kaye J. A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype. Am J Hum Genet. 1997 Apr;60(4):948-56.

Payami H, Zareparsi S, Montee KR, Sexton GJ, Kaye JA, Bird TD, Yu CE, Wijsman EM, Heston LL, Litt M, Schellenberg GD. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet. 1996 Apr;58(4):803-11.

Payami H, Montee K, Grimslid H, Shattuc S, Kaye J. Increased risk of familial late-onset Alzheimer's disease in women. Neurology. 1996 Jan;46(1):126-9.

Payami H, Bernard S, Larsen K, Kaye J, Nutt J. Genetic anticipation in Parkinson's disease. Neurology. 1995 Jan;45(1):135-8

Payami H, Montee KR, Kaye JA, Bird TD, Yu CE, Wijsman EM, Schellenberg GD. Alzheimer's disease, apolipoprotein E4, and gender. JAMA. 1994 May 4;271(17):1316-7. No abstract available.

Payami H, Montee K, Kaye J. Evidence for familial factors that protect against dementia and outweigh the effect of increasing age. Am J Hum Genet. 1994 Apr;54(4):650-7.

Yu CE, Payami H, Olson JM, Boehnke M, Wijsman EM, Orr HT, Kukull WA, Goddard KA, Nemens E, White JA, et al. The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease. Am J Hum Genet. 1994 Apr;54(4):631-42.

Payami H, Kaye J, Heston LL, Bird TD, Schellenberg GD. Apolipoprotein E genotype and Alzheimer's disease. Lancet. 1993 Sep 18;342(8873):738. No abstract available.

Schellenberg GD, Payami H, Wijsman EM, Orr HT, Goddard KA, Anderson L, Nemens E, White JA, Alonso ME, Ball MJ, et al. Chromosome 14 and late-onset familial Alzheimer disease (FAD). Am J Hum Genet. 1993 Sep;53(3):619-28.

Payami H, Hoffbuhr K. Lack of evidence for maternal effect in familial Alzheimer's disease. Genet Epidemiol. 1993;10(6):461-4.

Kamino K, Orr HT, Payami H, Wijsman EM, Alonso ME, Pulst SM, Anderson L, O'dahl S, Nemens E, White JA, et al. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region.
Am J Hum Genet. 1992 Nov;51(5):998-1014.

Payami H, Kaye J, Becker W, Norman D, Wetzsteon P. HLA-A2, or a closely linked gene, confers susceptibility to early-onset sporadic Alzheimer's disease in men. Neurology. 1991 Oct;41(10):1544-8.